86 related articles for article (PubMed ID: 8558520)
1. Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements.
Keyes RF; Golebiewski WM; Cushman M
J Med Chem; 1996 Jan; 39(2):508-14. PubMed ID: 8558520
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments.
Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Fanwick PE; Cushman M
Bioorg Med Chem; 2001 Nov; 9(11):2827-41. PubMed ID: 11597463
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues.
Golebiewski WM; Keyes RF; Cushman M
Bioorg Med Chem; 1996 Oct; 4(10):1637-48. PubMed ID: 8931933
[TBL] [Abstract][Full Text] [Related]
4. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency.
Cushman M; Insaf S; Paul G; Ruell JA; De Clercq E; Schols D; Pannecouque C; Witvrouw M; Schaeffer CA; Turpin JA; Williamson K; Rice WG
J Med Chem; 1999 May; 42(10):1767-77. PubMed ID: 10346929
[TBL] [Abstract][Full Text] [Related]
5. Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase.
Cushman M; Golebiewski WM; Pommier Y; Mazumder A; Reymen D; De Clercq E; Graham L; Rice WG
J Med Chem; 1995 Feb; 38(3):443-52. PubMed ID: 7853337
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction.
Cushman M; Golebiewski WM; McMahon JB; Buckheit RW; Clanton DJ; Weislow O; Haugwitz RD; Bader JP; Graham L; Rice WG
J Med Chem; 1994 Sep; 37(19):3040-50. PubMed ID: 7932526
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent.
Cushman M; Insaf S; Ruell JA; Schaeffer CA; Rice WG
Bioorg Med Chem Lett; 1998 Apr; 8(7):833-6. PubMed ID: 9871550
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain.
Casimiro-Garcia A; De Clercq E; Pannecouque C; Witvrouw M; Stup TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem; 2000 Jan; 8(1):191-200. PubMed ID: 10968278
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV activity of cosalane.
Choo V
Lancet; 1993 Sep; 342(8873):733. PubMed ID: 8103830
[No Abstract] [Full Text] [Related]
10. Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores.
Santhosh KC; Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Mar; 44(5):703-14. PubMed ID: 11262081
[TBL] [Abstract][Full Text] [Related]
11. Cosalane and its analogues: a unique class of anti-HIV agents.
Zhan P; Li Z; Liu X
Mini Rev Med Chem; 2010 Sep; 10(10):966-76. PubMed ID: 20540707
[TBL] [Abstract][Full Text] [Related]
12. Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem Lett; 2000 Sep; 10(18):2149-52. PubMed ID: 10999491
[TBL] [Abstract][Full Text] [Related]
13. 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones.
Artico M; Silvestri R; Massa S; Loi AG; Corrias S; Piras G; La Colla P
J Med Chem; 1996 Jan; 39(2):522-30. PubMed ID: 8558522
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transport of a novel anti-HIV agent--cosalane and its congeners across human intestinal epithelial (Caco-2) cell monolayers.
Udata C; Patel J; Pal D; Hejchman E; Cushman M; Mitra AK
Int J Pharm; 2003 Jan; 250(1):157-68. PubMed ID: 12480282
[TBL] [Abstract][Full Text] [Related]
16. Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers.
Udata C; Mitra AK; Badr MZ
Drug Metab Dispos; 1999 Aug; 27(8):947-50. PubMed ID: 10421624
[TBL] [Abstract][Full Text] [Related]
17. Anti-HIV activity of a series of cosalane amino acid conjugates.
Santhosh KC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem Lett; 2000 Nov; 10(22):2505-8. PubMed ID: 11086716
[TBL] [Abstract][Full Text] [Related]
18. Binding of cosalane--a novel highly lipophilic anti-HIV agent--to albumin and glycoprotein.
Kuchimanchi KR; Ahmed MS; Johnston TP; Mitra AK
J Pharm Sci; 2001 May; 90(5):659-66. PubMed ID: 11288110
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RANTES/CCR1-mediated chemotaxis by cosalane and related compounds.
Howard OM; Dong HF; Oppenheim JJ; Insaf S; Santhosh KC; Paul G; Cushman M
Bioorg Med Chem Lett; 2001 Jan; 11(1):59-62. PubMed ID: 11140734
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine.
Tsotinis A; Calogeropoulou T; Koufaki M; Souli C; Balzarini J; De Clercq E; Makriyannis A
J Med Chem; 1996 Aug; 39(17):3418-22. PubMed ID: 8765527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
